Profile

Nanology Labs is a Canadian biotechnology company focused on advancing the development of T-MX, a first-in-class nanomedicine that can improve therapeutic outcomes in the treatment of solid tumor cancers, leading to better survival and quality of life. The company also pursues collaborations with strategic partners to develop new precision medicines enabled by its proprietary drug delivery platform technology (TERP), which has a high degree of payload and targeting flexibility, with intrinsic capability for active transport into cells and across the blood-brain-barrier.

Nanology Labs Logo

Website

www.nanologylabs.com

Contact


Event details

Date: June 13 - 16, 2022

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

26 in total